Form 4: Bio-Key International Executive Acquires Shares Through Employee Stock Purchase Plan

James David Sullivan, Chief Legal Officer, SVP Strategy & Compliance at Bio-Key International, acquired 139 shares of common stock through the company's Employee Stock Purchase Plan.

Summary

• On June 28, 2024, James David Sullivan, Chief Legal Officer, SVP Strategy & Compliance at Bio-Key International, acquired 139 shares of common stock at a price of $1.394 per share.
• The acquisition was made through the BIO-key International, Inc. 2021 Employee Stock Purchase Plan and is exempt under Rule 16b-3(d) and Rule 16b-3(c).
• Following the transaction, Sullivan directly owns 22,073 shares of Bio-Key International.
• All share amounts reflect BIO-key's 1-for-18 reverse stock split, which was effective December 21, 2023.
• Holdings do not include options to purchase 348 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. An executive purchasing shares through an employee stock purchase plan is generally a good sign, but the amount is relatively small and doesn't provide a strong signal.

Positives

• Executive participation in the Employee Stock Purchase Plan can signal confidence in the company's future.

Industry Context

Insider transactions are closely monitored as they can provide insights into management's perspective on the company's valuation and future prospects. Purchases, especially by high-ranking officers, are often seen as a positive sign.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

BIO-key International, BKYI, James David Sullivan, Employee Stock Purchase Plan, Form 4, Insider Trading, Stock Acquisition, Reverse Stock Split